Hemenway Trust Hemenway Trust’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.2M Buy
230,183
+11,596
+5% +$1.34M 1.9% 22
2026
Q1
$26.1M Buy
218,587
+225
+0.1% +$29.5K 2.1% 22
2025
Q4
$29.7M Buy
218,362
+452
+0.2% +$65K 2.28% 19
2025
Q3
$32.1M Sell
217,910
-8,281
-4% -$1.15M 2.46% 19
2025
Q2
$29.3M Buy
226,191
+1,578
+0.7% +$191K 2.26% 21
2025
Q1
$26.8M Buy
224,613
+12,020
+6% +$1.49M 2.18% 22
2024
Q4
$24.7M Buy
212,593
+1,359
+0.6% +$172K 2% 23
2024
Q3
$28.5M Sell
211,234
-961
-0.5% -$129K 2.26% 23
2024
Q2
$28.8M Sell
212,195
-1,736
-0.8% -$236K 2.46% 20
2024
Q1
$27.6M Buy
213,931
+229
+0.1% +$27.7K 2.39% 20
2023
Q4
$24.4M Buy
213,702
+20,103
+10% +$2.01M 2.34% 22
2023
Q3
$17.6M Buy
193,599
+1,873
+1% +$193K 1.85% 25
2023
Q2
$21.6M Buy
191,726
+3,512
+2% +$371K 2.12% 22
2023
Q1
$19.7M Buy
188,214
+6,023
+3% +$629K 2.09% 22
2022
Q4
$20.1M Buy
182,191
+5,922
+3% +$621K 2.24% 20
2022
Q3
$15.4M Buy
176,269
+2,490
+1% +$226K 1.81% 24
2022
Q2
$13.6M Buy
173,779
+9,959
+6% +$822K 1.55% 28
2022
Q1
$14M Buy
163,820
+8,093
+5% +$775K 1.34% 31
2021
Q4
$18.7M Buy
155,727
+3,712
+2% +$461K 1.7% 28
2021
Q3
$18.8M Buy
152,015
+1,142
+0.8% +$147K 1.9% 21
2021
Q2
$18.1M Buy
150,873
+11,193
+8% +$1.28M 1.82% 24
2021
Q1
$14.7M Buy
139,680
+30,675
+28% +$3.11M 1.61% 28
2020
Q4
$11.1M Buy
109,005
+9,797
+10% +$921K 1.27% 33
2020
Q3
$8.35M Buy
99,208
+11,031
+13% +$859K 1.08% 36
2020
Q2
$5.73M Buy
88,177
+7,816
+10% +$516K 0.8% 37
2020
Q1
$5.23M Buy
80,361
+5,488
+7% +$432K 0.88% 36
2019
Q4
$5.9M Buy
74,873
+4,155
+6% +$323K 0.85% 35
2019
Q3
$5.63M Buy
70,718
+6,416
+10% +$504K 0.88% 34
2019
Q2
$5.38M Buy
64,302
+3,915
+6% +$312K 0.83% 35
2019
Q1
$4.77M Buy
60,387
+13,396
+29% +$978K 0.77% 38
2018
Q4
$3.13M Sell
46,991
-11,948
-20% -$827K 0.64% 41
2018
Q3
$4.71M Sell
58,939
-358
-0.6% -$26.7K 0.79% 37
2018
Q2
$4M Sell
59,297
-3,093
-5% -$225K 0.74% 39
2018
Q1
$4.8M Buy
62,390
+269
+0.4% +$19.9K 0.91% 36
2017
Q4
$4.24M Buy
62,121
+2,166
+4% +$144K 0.81% 37
2017
Q3
$3.75M Buy
59,955
+5,079
+9% +$304K 0.78% 38
2017
Q2
$3.04M Buy
54,876
+5,980
+12% +$311K 0.68% 39
2017
Q1
$2.46M Buy
48,896
+260
+0.5% +$12.7K 0.57% 43
2016
Q4
$2.41M Buy
48,636
+3,510
+8% +$178K 0.61% 46
2016
Q3
$2.37M Buy
45,126
+2,590
+6% +$127K 0.59% 47
2016
Q2
$1.9M Buy
42,536
+6,975
+20% +$303K 0.5% 48
2016
Q1
$1.45M Sell
35,561
-1,055
-3% -$38.8K 0.39% 54
2015
Q4
$1.34M Buy
36,616
+2,875
+9% +$104K 0.35% 56
2015
Q3
$1.11M Sell
33,741
-61,650
-65% -$2.07M 0.31% 60
2015
Q2
$3.54M Buy
95,391
+2,750
+3% +$100K 0.91% 41
2015
Q1
$3.24M Buy
92,641
+5,465
+6% +$193K 0.85% 44
2014
Q4
$3.32M Buy
87,176
+21,345
+32% +$781K 0.99% 40
2014
Q3
$2.34M Buy
65,831
+19,300
+41% +$717K 0.73% 45
2014
Q2
$1.82M Buy
+46,531
New +$1.74M 0.55% 48

Other funds holding XYL

Hemenway Trust Hemenway Trust's XYL Position: Q2 2026 in Review

Hemenway Trust Hemenway Trust increased its Xylem (XYL) stake by 5.3% in Q2 2026, buying an estimated $1.34M and bringing the position to 230,183 shares worth $27.2M. The position accounts for 1.9% of the portfolio, ranked #22.

Hemenway Trust Hemenway Trust first reported a position in XYL in Q2 2014 and has held it in 49 quarters since. The position peaked at $32.1M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Hemenway Trust Hemenway Trust held 230,183 shares of Xylem worth $27.2M as of Q2 2026.
  • Hemenway Trust Hemenway Trust bought 11,596 Xylem shares in Q2 2026, an estimated $1.34M.
  • Xylem made up 1.9% of Hemenway Trust Hemenway Trust's portfolio in Q2 2026, its #22 holding.
  • Hemenway Trust Hemenway Trust first reported a position in Xylem in Q2 2014 and has held it in 49 quarters since.
  • Hemenway Trust Hemenway Trust's Xylem position peaked at $32.1M in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q2 2026, filed 11 Aug 2026.